Starpharma Holdings (SPL) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

System message

Download 6 FREE classic investment books - CLICK HERE

Starpharma Holdings Chart

Share price
Last
Change
Volume
Turnover
Market Cap $602.14 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

SPL Statistics

01 October

328 / 2,340

ASX Size Rank

1yr Return

vs Sector (1yr)

-11.60%

vs ASX 200 (1yr)

+18.81%

$602.14 million

Market Cap

Share Issue

370.54 million

All Ords (%)

0.03%

Short Sold

2.18%

Current Fundamentals

01 October

N/A

PE Ratio

EPS ($)

-0.028

Earnings Yield

-1.71%

NTA ($)

0.14

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Starpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL's underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses. SPL has three core development programs: VivaGel portfolio, drug delivery, and agrochemicals.

Former Names
Starpharma Pooled Development Limited (SPL), 20/04/2004.

Starpharma Holdings Logo

Corporate Details

Head Office: Abbotsford
Managing Director: Jacinth (Jackie) Fairley
GICS Sub-Industry: Pharmaceuticals
Date Listed: 28 Sep 2000
Registry: Computershare
Similar Companies: MYX / CAN / MVP / NEU

Upcoming Calendar

25 Feb 2019 Report (Interim)
20 Aug 2019 Report (Prelim)
20 Aug 2019 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

SPL is not covered by a major broker.

Directors & Management

About the Data


Name Title Since Bio
Ms Zita Peach Non-Executive Director Oct 2011
Mr Robert Bain Thomas Non-Executive Director, Non-Executive Chairman Dec 2013
Dr Jacinth (Jackie) Kincaid Fairley Chief Executive Officer, Executive Director Jul 2006
Mr Peter R Turvey Non-Executive Director Mar 2012
Mr Richard A Hazelton Non-Executive Director Dec 2006
Nigel Baade Chief Financial Officer, Company Secretary N/A
A Eglezos Vice President, Business Development N/A
J R Paull Vice President, Development & Regulatory Affairs N/A
D J Owen Vice President, Research N/A

Director Transactions

About the Data

SPL directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
16/05/18 Robert Thomas Buy +25,000 $1.260 $31,500 On-market trade.
21/03/18 Jacinth (Jackie) Fairley Buy +20,000 $1.185 $23,701 On-market trade.
19/03/18 Robert Thomas Buy +25,000 $1.255 $31,375 On-market trade.
14/03/18 Robert Thomas Buy +25,000 $1.280 $32,005 On-market trade.
09/03/18 Jacinth (Jackie) Fairley Buy +25,000 $1.440 $36,000 On-market trade.
09/03/18 Jacinth (Jackie) Fairley Sell -37,138 $1.370 ($50,889) On-market trade.
08/03/18 Peter Turvey Buy +17,983 $1.380 $24,815 On-market trade.
28/02/18 Robert Thomas Buy +25,000 $1.440 $36,000 On-market trade.
11/12/17 Jacinth (Jackie) Fairley Issued 1,120,000 $1.380 $1,545,600 Issue of securities.
05/12/17 Robert Thomas Buy +25,000 $1.376 $34,388 On-market trade.
06/11/17 Jacinth (Jackie) Fairley Buy +25,000 $1.420 $35,500 On-market trade.
30/10/17 Robert Thomas Buy +25,000 $1.352 $33,800 On-market trade.
05/10/17 Jacinth (Jackie) Fairley Issued 556,500 $1.320 $734,580 Conversion of securities.
05/10/17 Jacinth (Jackie) Fairley Cancelled 243,680 $1.320 $321,657 Cancellation of securities.
05/10/17 Jacinth (Jackie) Fairley Exercise 556,500 $1.320 $734,580 Conversion of securities.
05/12/16 Jacinth (Jackie) Fairley Issued 1,100,000 $0.740 $814,000
05/12/16 Jacinth (Jackie) Fairley Expiry 150,000 $0.740 $111,000
05/12/16 Jacinth (Jackie) Fairley Buy +100,000 $0.740 $74,000
05/12/16 Jacinth (Jackie) Fairley Exercise 100,000 $0.740 $74,000
02/12/16 Robert Thomas Buy +25,000 $0.680 $17,000
17/10/16 Robert Thomas Buy +25,000 $0.615 $15,375
13/10/16 Jacinth (Jackie) Fairley Expiry 38,394 $0.610 $23,420
07/10/16 Jacinth (Jackie) Fairley Expiry 45,000 $0.630 $28,350
07/10/16 Jacinth (Jackie) Fairley Buy +405,000 $0.630 $255,150
07/10/16 Jacinth (Jackie) Fairley Exercise 405,000 $0.630 $255,150
16/09/16 Robert Thomas Buy +25,000 $0.665 $16,625
16/05/16 Robert Thomas Buy +25,000 $0.710 $17,750
22/01/16 Jacinth (Jackie) Fairley Buy +20,548 $0.730 $15,000
22/01/16 Robert Thomas Buy +20,548 $0.730 $15,000
22/01/16 Peter Turvey Buy +20,548 $0.730 $15,000
22/01/16 Zita Peach Buy +20,548 $0.730 $15,000
17/12/15 Robert Thomas Buy +29,452 $0.710 $20,910
04/12/15 Jacinth (Jackie) Fairley Expiry 430,000 $0.780 $335,400
04/12/15 Jacinth (Jackie) Fairley Buy +130,000 $0.780 $101,400
04/12/15 Jacinth (Jackie) Fairley Exercise 130,000 $0.780 $101,400
04/12/15 Jacinth (Jackie) Fairley Issued 1,113,246 $0.780 $868,331
09/10/15 Jacinth (Jackie) Fairley Expiry 21,750 $0.755 $16,421
09/10/15 Jacinth (Jackie) Fairley Exercise 278,250 $0.755 $210,078
09/10/15 Jacinth (Jackie) Fairley Buy +278,250 $0.755 $210,078
22/09/15 Robert Thomas Buy +25,000 $0.710 $17,750
18/09/15 Richard Hazelton Buy +25,000 $0.698 $17,455
10/09/15 Peter Turvey Buy +41,213 $0.720 $29,673
09/09/15 Robert Thomas Buy +50,000 $0.720 $36,000
09/09/15 Jacinth (Jackie) Fairley Buy +50,000 $0.733 $36,650
09/09/15 Zita Peach Buy +13,888 $0.728 $10,107
20/05/15 Jacinth (Jackie) Fairley Buy +477,500 $0.740 $353,350
20/05/15 Jacinth (Jackie) Fairley Sell -477,500 $0.740 ($353,350)
18/12/14 Robert Thomas Buy +50,000 $0.510 $25,499
16/12/14 Jacinth (Jackie) Fairley Buy +100,000 $0.434 $43,447
05/12/14 Robert Thomas Buy +56,923 $0.505 $28,746
03/12/14 Jacinth (Jackie) Fairley Expiry 150,000 $0.520 $78,000
03/12/14 Jacinth (Jackie) Fairley Issued 1,500,000 $0.520 $780,000
03/12/14 Jacinth (Jackie) Fairley Exercise 50,000 $0.520 $26,000
03/12/14 Jacinth (Jackie) Fairley Issued 50,000 $0.520 $26,000
05/11/14 Peter Jenkins Buy +33,849 $0.650 $22,000
05/11/14 Zita Peach Buy +11,539 $0.650 $7,500
05/11/14 Peter Turvey Buy +23,077 $0.650 $15,000
05/11/14 Jacinth (Jackie) Fairley Buy +23,077 $0.650 $15,000
05/11/14 Robert Thomas Buy +23,077 $0.650 $15,000
03/11/14 Richard Hazelton Buy +25,850 $0.555 $14,346
14/10/14 Jacinth (Jackie) Fairley Buy +465,000 $0.650 $302,250
14/10/14 Jacinth (Jackie) Fairley Exercise 465,000 $0.650 $302,250
14/10/14 Jacinth (Jackie) Fairley Expiry 35,000 $0.650 $22,750
27/06/14 Jacinth (Jackie) Fairley Sell -100,000 $0.576 ($57,550)
26/06/14 Jacinth (Jackie) Fairley Sell -40,000 $0.566 ($22,650)
25/06/14 Jacinth (Jackie) Fairley Sell -220,000 $0.567 ($124,648)
24/06/14 Robert Thomas Buy +50,000 $0.567 $28,336
23/06/14 Robert Thomas Buy +50,000 $0.580 $29,000
06/12/13 Jacinth (Jackie) Fairley Issued 950,000 $0.830 $788,500
02/10/13 Jacinth (Jackie) Fairley Expiry 200,000 $1.005 $201,000
02/10/13 Jacinth (Jackie) Fairley Exercise 200,000 $1.005 $201,000
02/10/13 Jacinth (Jackie) Fairley Buy +200,000 $1.005 $201,000
05/06/13 Jacinth (Jackie) Fairley Buy +25,000 $0.830 $20,741
05/04/13 Zita Peach Buy +1,000 $1.120 $1,120
07/03/13 Richard Hazelton Buy +15,000 $1.150 $17,250

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 1,293 2,075 997 1,453 271 6,089

Top 20 Shareholders

About the Data

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 120,044,106 32.40%
JP Morgan Nominees Australia Limited 38,445,033 10.38%
Citicorp Nominees Pty Limited 31,485,303 8.50%
National Nominees Limited 10,491,864 2.83%
T & N Argyrides Investments P/L 5,250,592 1.42%
BNP Paribas Noms Pty Ltd 4,394,597 1.19%
Applecross Secretarial Services Pty Ltd 3,361,550 0.91%
Mr Peter Murray Jackson 3,170,000 0.86%
HSBC Custody Nominees (Australia) Limited A/C 2 2,820,006 0.76%
Mr Kingsley Bryan Bartholomew 2,517,072 0.68%
Mirrabooka Investments Limited 2,500,000 0.67%
Ms Jacinth Fairley 2,190,886 0.59%
Dollar Coin Investments 1,996,850 0.54%
Merrill Lynch (Australia) Nominees Pty Limited 1,686,935 0.46%
Commonwealth Scientific and Industrial Research Organisation 1,448,798 0.39%
Mr Mario Argyrides 1,439,900 0.39%
BNP Paribas Nominees Pty Ltd 1,416,667 0.38%
Mr Nicholas Wheeler 1,350,000 0.36%
Mr David Michael Hosey + Mrs Andrea Jane Hosey 1,213,718 0.33%
Gilridge Pty Ltd 1,120,267 0.30%
All other shareholders 35.66 %


The Top 20 Shareholders of SPL hold 64.34% of shares on issue.

SPL Share Price History

Date Close Change % Change Open High Low Volume Turnover

SPL Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2018 $1.165 29 June
2017 $0.73 28 June
2016 $0.645 28 June
2015 $0.73 30 June
2014 $0.58 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Research, development and commercialisation of dendrimer products for pharmaceutical, life-science and other applications.

Incorporated: in VIC on 13/05/1997. Name changed to Starpharma Holdings Limited on 21/04/2004. Suspended from quotation on 11/11/2005. Reinstated to quotation on 14/11/2005.

4 - 6 Southampton Cres
Abbotsford VIC 3067

Tinsulate
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.